198 related articles for article (PubMed ID: 31417638)
1. The role of postoperative radiotherapy for completely resected pIIIA-N2 non-small cell lung cancer patients with different clinicopathological features: a systemic review and meta-analysis.
Liu T; Mu Y; Dang J; Li G
J Cancer; 2019; 10(17):3941-3949. PubMed ID: 31417638
[No Abstract] [Full Text] [Related]
2. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
[TBL] [Abstract][Full Text] [Related]
3. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M
Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986
[TBL] [Abstract][Full Text] [Related]
4. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
5. Effect of postoperative radiotherapy on survival in patients with completely resected and pathologically confirmed stage N2 non-small-cell lung cancer: a systematic review and meta-analysis.
Wang L; Chen W; Xu X; Chen W; Bao D; Zhang Y; Xu Y
Ther Adv Chronic Dis; 2023; 14():20406223231195622. PubMed ID: 37720592
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal radiotherapy after adjuvant chemotherapy for resected non-small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis.
Harling L; Jayakumar S; Ashrafian H; Bille A; Toufektzian L; Smith D
JTCVS Open; 2021 Mar; 5():121-130. PubMed ID: 36003173
[TBL] [Abstract][Full Text] [Related]
7. Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.
Hui Z; Dai H; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Wang L
Thorac Cancer; 2015 May; 6(3):346-53. PubMed ID: 26273382
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
Gao F; Li N; Xu Y; Yang G
Front Oncol; 2020; 10():1135. PubMed ID: 32850322
[No Abstract] [Full Text] [Related]
9. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy in pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: A meta-analysis.
Wang SF; Mao NQ; Zhao WH; Pan XB
Medicine (Baltimore); 2022 Jul; 101(28):e29550. PubMed ID: 35839025
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Lei T; Li J; Zhong H; Zhang H; Jin Y; Wu J; Li L; Xu B; Song Q; Hu Q
Front Oncol; 2021; 11():680615. PubMed ID: 34336667
[TBL] [Abstract][Full Text] [Related]
12. The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis.
Zhang H; Zhang DX; Ju T; Zhou J
Neoplasma; 2019 Sep; 66(5):717-726. PubMed ID: 31129967
[TBL] [Abstract][Full Text] [Related]
13. A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer.
Olmetto E; Perna M; Cerbai C; Aquilano M; Banini M; Mariotti M; Livi L; Scotti V
Mediastinum; 2022; 6():4. PubMed ID: 35340837
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of postoperative radiotherapy in pIII-N2 non-small cell lung cancer after complete resection followed by adjuvant chemotherapy: a systematic review and meta-analysis.
Kim IH; Yun JK
J Thorac Dis; 2024 Mar; 16(3):1815-1824. PubMed ID: 38617755
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy for patients with completely resected stage IIIA-N2 non-small cell lung cancer: opt-in or opt-out.
Zhu L; Xia B; Ma S
Thorac Cancer; 2022 Mar; 13(5):659-663. PubMed ID: 35106937
[TBL] [Abstract][Full Text] [Related]
17. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Liu F; Li B
Oncol Lett; 2023 May; 25(5):205. PubMed ID: 37123022
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer.
Lei T; Xu XL; Chen W; Xu YP; Mao WM
Onco Targets Ther; 2016; 9():921-8. PubMed ID: 26966380
[TBL] [Abstract][Full Text] [Related]
20. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
